Researchers isolate first 'neuroprotective' gene in patients with amyotrophic lateral sclerosis

A genetic variant that substantially improves survival of individuals with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, has been indentified by a consortium of researchers led by John Landers, PhD, Associate Professor of Neurology and Robert Brown, MD, DPhil, Chair and Professor of Neurology at the University of Massachusetts Medical School. Discovery of the KIFAP3 gene variant is reported in the Proceedings of the National Academy of Sciences.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news161315545.html">Researchers isolate first 'neuroprotective' gene in patients with amyotrophic lateral sclerosis</a></p> <p> A genetic variant that substantially improves survival of individuals with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, has been indentified by a consortium of researchers led by John Landers, PhD, Associate Professor of Neurology and Robert Brown, MD, DPhil, Chair and Professor of Neurology at the University of Massachusetts Medical School. Discovery of the KIFAP3 gene variant is reported in the <i>Proceedings of the National Academy of Sciences</i>.</p>